칼비스타 파마슈티컬스(KalVista Pharmaceuticals, Inc.)
US ˙ NasdaqGM ˙ US4834971032

SecurityKALV / KalVista Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership66,313 shares
Latest Disclosed Value $ 749,668
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in KALV / KalVista Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 66,313 shares of KalVista Pharmaceuticals, Inc. (US:KALV) valued at $749,668 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 66,313 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,787,135 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP KalVista Pharmaceuticals EC US4834971032 66,313 0 0.00 750 -2.09 0.0168
2025-05-28 2025-03-31 NP KalVista Pharmaceuticals EC US4834971032 66,313 8,846 15.39 765 57.41 0.0184
2025-02-25 2024-12-31 NP KalVista Pharmaceuticals EC US4834971032 57,467 -18,466 -24.32 487 -44.71 0.0106
2024-11-26 2024-09-30 NP KalVista Pharmaceuticals EC US4834971032 75,933 17,567 30.10 879 27.95 0.0166
2024-08-26 2024-06-30 NP KalVista Pharmaceuticals EC US4834971032 58,366 15,533 36.26 688 35.50 0.0140
2024-05-28 2024-03-31 NP KalVista Pharmaceuticals EC US4834971032 42,833 0 0.00 508 -3.24 0.0106
2024-02-26 2023-12-31 NP KalVista Pharmaceuticals EC US4834971032 42,833 0 0.00 525 27.18 0.0112
2023-11-28 2023-09-30 NP KalVista Pharmaceuticals EC US4834971032 42,833 0 0.00 412 7.01 0.0108
2023-08-25 2023-06-30 NP KalVista Pharmaceuticals EC US4834971032 42,833 5,146 13.65 385 30.07 0.0091
2023-05-26 2023-03-31 NP KalVista Pharmaceuticals EC US4834971032 37,687 0 0.00 296 16.54 0.0079
2023-02-24 2022-12-31 NP KalVista Pharmaceuticals EC US4834971032 37,687 0 0.00 255 -53.48 0.0070
2022-11-25 2022-09-30 NP KalVista Pharmaceuticals EC US4834971032 37,687 3,764 11.10 547 63.96 0.0157
2022-08-25 2022-06-30 NP KalVista Pharmaceuticals EC US4834971032 33,923 0 0.00 334 -33.40 0.0092
2022-05-26 2022-03-31 NP KalVista Pharmaceuticals EC US4834971032 33,923 0 0.00 500 11.61 0.0116
2022-02-25 2021-12-31 NP KalVista Pharmaceuticals EC US4834971032 33,923 5,384 18.87 449 -10.04 0.0097
2021-11-24 2021-09-30 NP KalVista Pharmaceuticals EC US4834971032 28,539 0 0.00 498 -27.09 0.0110
2021-08-26 2021-06-30 NP KalVista Pharmaceuticals EC US4834971032 28,539 0 0.00 684 -6.82 0.0147
2021-05-27 2021-03-31 NP KalVista Pharmaceuticals EC US4834971032 28,539 7,592 36.24 733 84.63 0.0166
2021-02-25 2020-12-31 NP KalVista Pharmaceuticals EC US4834971032 20,947 0 0.00 398 50.95 0.0102
2020-11-25 2020-09-30 NP KalVista Pharmaceuticals EC US4834971032 20,947 0 0.00 264 3.95 0.0085
2020-08-27 2020-06-30 NP KalVista Pharmaceuticals EC US4834971032 20,947 963 4.82 253 66.45 0.0083
2020-06-01 2020-03-31 NP KalVista Pharmaceuticals EC US4834971032 19,984 2,283 12.90 153 -51.75 0.0062
2020-02-27 2019-12-31 NP KalVista Pharmaceuticals EC 483497103 17,701 0 0.00 315 53.66 0.0095
2019-11-27 2019-09-30 NP KalVista Pharmaceuticals EC US4834971032 17,701 17,701 205 0.0068
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.